Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
temozolomid ebb 100 mg kapsel, hård
ebb medical ab - temozolomid - kapsel, hård - 100 mg - propylenglykol hjälpämne; temozolomid 100 mg aktiv substans; laktos (vattenfri) hjälpämne
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastiska medel - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.